369 related articles for article (PubMed ID: 10452325)
1. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner R; Wester HJ; Reuning U; Senekowitsch-Schmidtke R; Diefenbach B; Kessler H; Stöcklin G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):1061-71. PubMed ID: 10452325
[TBL] [Abstract][Full Text] [Related]
2. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics.
Haubner R; Wester HJ; Burkhart F; Senekowitsch-Schmidtke R; Weber W; Goodman SL; Kessler H; Schwaiger M
J Nucl Med; 2001 Feb; 42(2):326-36. PubMed ID: 11216533
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography.
Haubner R; Wester HJ; Weber WA; Mang C; Ziegler SI; Goodman SL; Senekowitsch-Schmidtke R; Kessler H; Schwaiger M
Cancer Res; 2001 Mar; 61(5):1781-5. PubMed ID: 11280722
[TBL] [Abstract][Full Text] [Related]
4. Radiolabeled RGD uptake and alphav integrin expression is enhanced in ischemic murine hindlimbs.
Lee KH; Jung KH; Song SH; Kim DH; Lee BC; Sung HJ; Han YM; Choe YS; Chi DY; Kim BT
J Nucl Med; 2005 Mar; 46(3):472-8. PubMed ID: 15750161
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
[TBL] [Abstract][Full Text] [Related]
6. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of a (99m)Tc-labelled cyclic RGD peptide for imaging the alphavbeta3 expression.
Haubner R; Bruchertseifer F; Bock M; Kessler H; Schwaiger M; Wester HJ
Nuklearmedizin; 2004 Feb; 43(1):26-32. PubMed ID: 14978538
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral spatial distribution of hypoxia and angiogenesis assessed by 18F-FAZA and 125I-Gluco-RGD autoradiography.
Picchio M; Beck R; Haubner R; Seidl S; Machulla HJ; Johnson TD; Wester HJ; Reischl G; Schwaiger M; Piert M
J Nucl Med; 2008 Apr; 49(4):597-605. PubMed ID: 18344437
[TBL] [Abstract][Full Text] [Related]
10. Localization of iodine-125-mIP-Des-Met14-bombesin (7-13)NH2 in ovarian carcinoma induced to express the gastrin releasing peptide receptor by adenoviral vector-mediated gene transfer.
Rogers BE; Rosenfeld ME; Khazaeli MB; Mikheeva G; Stackhouse MA; Liu T; Curiel DT; Buchsbaum DJ
J Nucl Med; 1997 Aug; 38(8):1221-9. PubMed ID: 9255155
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 64Cu- and 125I-radiolabeled bitistatin as potential agents for targeting alpha v beta 3 integrins in tumor angiogenesis.
McQuade P; Knight LC; Welch MJ
Bioconjug Chem; 2004; 15(5):988-96. PubMed ID: 15366951
[TBL] [Abstract][Full Text] [Related]
12. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
13. Complementary, Selective PET Imaging of Integrin Subtypes α5β1 and αvβ3 Using 68Ga-Aquibeprin and 68Ga-Avebetrin.
Notni J; Steiger K; Hoffmann F; Reich D; Kapp TG; Rechenmacher F; Neubauer S; Kessler H; Wester HJ
J Nucl Med; 2016 Mar; 57(3):460-6. PubMed ID: 26635338
[TBL] [Abstract][Full Text] [Related]
14. Effect of multimerization of a linear Arg-Gly-Asp peptide on integrin binding affinity and specificity.
Jin ZH; Furukawa T; Waki A; Akaji K; Coll JL; Saga T; Fujibayashi Y
Biol Pharm Bull; 2010; 33(3):370-8. PubMed ID: 20190395
[TBL] [Abstract][Full Text] [Related]
15. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
[TBL] [Abstract][Full Text] [Related]
16. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide.
Chen X; Park R; Tohme M; Shahinian AH; Bading JR; Conti PS
Bioconjug Chem; 2004; 15(1):41-9. PubMed ID: 14733582
[TBL] [Abstract][Full Text] [Related]
17. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evaluation of a Technetium-99m-labeled cyclic RGD peptide as a specific marker of alpha(V)beta(3) integrin for tumor imaging.
Su ZF; Liu G; Gupta S; Zhu Z; Rusckowski M; Hnatowich DJ
Bioconjug Chem; 2002; 13(3):561-70. PubMed ID: 12009947
[TBL] [Abstract][Full Text] [Related]
19. Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.
Jang BS; Lim E; Hee Park S; Shin IS; Danthi SN; Hwang IS; Le N; Yu S; Xie J; Li KC; Carrasquillo JA; Paik CH
Nucl Med Biol; 2007 May; 34(4):363-70. PubMed ID: 17499725
[TBL] [Abstract][Full Text] [Related]
20. Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma.
Cheng Z; Chen J; Quinn TP; Jurisson SS
Cancer Res; 2004 Feb; 64(4):1411-8. PubMed ID: 14973076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]